Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Conditions: Relapsing Multiple Sclerosis; Relapsing Remitting Multiple Sclerosis; Secondary Progressive Multiple Sclerosis Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation; Biological: Best Available Therapy (BAT) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Multiple Sclerosis | Research | Stem Cell Therapy | Stem Cells | Transplants